Episode Details
Back to EpisodesE48: ADACTA - Tocilizumab or Adalimumab in MTX Intolerant Patients with RA
Episode 49
Published 6 years, 6 months ago
Description
This week I revisit an old paper - the 2013 ADACTA trial that assessed tocilizumab and adalimumab for patients who cannot take or were intolerant of MTX.